首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma: a retrospective study of local recurrence and long-term survival rates in 120 patients with hepatocellular carcinoma.
【24h】

Excellent outcomes with angiographic subsegmentectomy in the treatment of typical hepatocellular carcinoma: a retrospective study of local recurrence and long-term survival rates in 120 patients with hepatocellular carcinoma.

机译:血管造影亚段切除术在典型肝细胞癌治疗中的优异结果:对120例肝细胞癌患者局部复发和长期生存率的回顾性研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The authors successfully adopted an interesting and effective treatment for hepatocellular carcinoma (HCC) referred to as angiographic subsegmentectomy (AS). This treatment involved simultaneous embolization of the peripheral feeding artery and the portal vein. The result was that almost all of the HCC and peripheral liver parenchyma developed complete anatomic necrosis. METHODS: To determine the effectiveness of this method, the authors retrospectively studied the local recurrence rates of 49 solitary HCCs and the long-term survival rates of 120 patients with HCC between 2000 and 2008. RESULTS: The results indicated that, in 31 small, solitary HCCs (<2.0 cm), the local recurrence rate was only 9.6%; and, in 10 slightly larger HCCs (<3.0 cm), the local recurrence rate was only 10%. The 5-year, 8-year, and 10-year survival rates for patients with stage I and stage I/Child-Pugh grade A HCC were 74.27% and 77.65%, 53.05% and 51.76%, and 53% and 51.76%, respectively; and the 5-year, 8-year, and 10-year survival rates for patients with stage II and stage II/Child-Pugh grade A HCC were 66.21% and 71.41%, 39.9% and 39.60%, and 29.92% and 25%), respectively. There were no severe complications. CONCLUSIONS: AS should be investigated further as potential first-line therapy for the treatment of patients with stage I and II HCC.
机译:背景:作者成功地对肝细胞癌(HCC)采取了一种有趣而有效的治疗方法,称为血管造影亚段切除术(AS)。该治疗涉及同时对外周进给动脉和门静脉进行栓塞。结果是几乎所有的HCC和周围肝实质均发生了完整的解剖坏死。方法:为确定该方法的有效性,作者回顾性研究了2000年至2008年间49例孤立HCC的局部复发率和120例HCC的长期生存率。结果:结果表明,在31例小肝癌中,单独的肝癌(<2.0 cm),局部复发率仅为9.6%;在10个稍大的HCC(<3.0 cm)中,局部复发率仅为10%。 I期和I期/ Child-Pugh A级HCC患者的5年,8年和10年生存率分别为74.27%和77.65%,53.05%和51.76%,53%和51.76%,分别; II期和II期/ Child-Pugh A级HCC患者的5年,8年和10年生存率分别为66.21%和71.41%,39.9%和39.60%,29.92%和25% ), 分别。没有严重的并发症。结论:AS应作为I,II期HCC患者的潜在一线治疗方法进行进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号